Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 29;7(1):00754-2020.
doi: 10.1183/23120541.00754-2020. eCollection 2021 Jan.

Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study

Affiliations

Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study

Bashar N Alzghoul et al. ERJ Open Res. .

Abstract

Little is known about the prevalence, clinical characteristics and impact of hypothyroidism in patients with sarcoidosis. We aimed to determine the prevalence and clinical features of hypothyroidism and its relation to organ involvement and other clinical manifestations in patients with sarcoidosis. We conducted a national registry-based study investigating 3835 respondents to the Sarcoidosis Advanced Registry for Cures Questionnaire between June 2014 and August 2019. This registry is based on a self-reported, web-based questionnaire that provides data related to demographics, diagnostics, sarcoidosis manifestations and treatment. We compared sarcoidosis patients with and without self-reported hypothyroidism. We used multivariable logistic regression and adjusted for potential confounders to determine the association of hypothyroidism with nonorgan-specific manifestations. 14% of the sarcoidosis patients self-reported hypothyroidism and were generally middle-aged white women. Hypothyroid patients had more comorbid conditions and were more likely to have multiorgan sarcoidosis involvement, especially with cutaneous, ocular, joints, liver and lacrimal gland involvement. Self-reported hypothyroidism was associated with depression (adjusted odds ratio (aOR) 1.3, 95% CI 1.01-1.6), antidepressant use (aOR 1.3, 95% CI 1.1-1.7), obesity (aOR 1.7, 95% CI 1.4-2.1), sleep apnoea (aOR 1.7, 95% CI 1.3-2.2), chronic fatigue syndrome (aOR 1.5, 95% CI 1.2-2) and was borderline associated with fibromyalgia (aOR 1.3, 95% CI 1-1.8). Physical impairment was more common in patients with hypothyroidism. Hypothyroidism is a frequent comorbidity in sarcoidosis patients that might be a potentially reversible contributor to fatigue, depression and physical impairment in this population. We recommend considering routine screening for hypothyroidism in sarcoidosis patients especially in those with multiorgan sarcoidosis, fatigue and depression.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: B.N. Alzghoul has nothing to disclose. Conflict of interest: F.N. Amer has nothing to disclose. Conflict of interest: D. Barb has nothing to disclose. Conflict of interest: A. Innabi has nothing to disclose. Conflict of interest: M.T. Mardini has nothing to disclose. Conflict of interest: C. Bai has nothing to disclose. Conflict of interest: B. Alzghoul has nothing to disclose. Conflict of interest: T. Al-Hakim reports helping with the FSR-SARC registry design and enrollment. Conflict of interest: N. Singh reports helping with the FSR-SARC registry design and enrollment. Conflict of interest: M. Buchanan reports helping with the FSR-SARC registry design and enrollment. Conflict of interest: L. Serchuck reports helping with the FSR-SARC registry design and enrollment. Conflict of interest: D. Gomez Manjarres has nothing to disclose. Conflict of interest: W.W. Woodmansee has nothing to disclose. Conflict of interest: L.A. Maier reports being a nonpaid member of the Scientific Advisory Board of the FSR, and receives grant funding for research as a member of the FSR-Clinical Studies Network. She helped with the FSR-SARC registry design and enrolment. Conflict of interest: D.C. Patel has nothing to disclose.

Figures

FIGURE 1
FIGURE 1
Clustered bar chart demonstrating the frequencies of other endocrine and vitamin D disorders in sarcoidosis patients with hypothyroidism as compared with those with no hypothyroidism.
FIGURE 2
FIGURE 2
Forest plot showing the adjusted odds ratio of the likelihood of different nonorgan-specific conditions in patients with sarcoidosis who also have hypothyroidism versus those with no hypothyroidism. Odds ratio with confidence intervals are based on multivariable logistic regression analysis adjusted for sex, race, age at diagnosis, healthcare insurance status, use of steroids, multiorgan involvement and other sarcoidosis-related comorbidities (cancer, chronic pain syndrome, congestive heart failure and lymphoma).

Similar articles

Cited by

References

    1. Sauer WH, Stern BJ, Baughman RP, et al. . High-risk sarcoidosis. Current concepts and research imperatives. Ann Am Thorac Soc 2017; 14: S437–S444. doi:10.1513/AnnalsATS.201707-566OT - DOI - PubMed
    1. Drent M, Lower EE, Vries JD. Sarcoidosis-associated fatigue. Eur Respir J 2012; 40: 255–263. doi:10.1183/09031936.00002512 - DOI - PubMed
    1. Wu C-H, Chung P-I, Wu C-Y, et al. . Comorbid autoimmune diseases in patients with sarcoidosis: a nationwide case–control study in Taiwan. J Dermatol 2017; 44: 423–430. doi:10.1111/1346-8138.13654 - DOI - PubMed
    1. Korsten P, Tampe B, Konig MF, et al. . Sarcoidosis and autoimmune diseases: differences, similarities and overlaps. Curr Opin Pulm Med 2018; 24: 504–512. doi:10.1097/MCP.0000000000000500 - DOI - PubMed
    1. Fazzi P, Fallahi P, Ferrari SM. Sarcoidosis and thyroid autoimmunity. Front Endocrinol (Lausanne) 2017; 8: 177. doi:10.3389/fendo.2017.00177 - DOI - PMC - PubMed

LinkOut - more resources